Allianz Asset Management’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $30.7M | Buy |
110,241
+37
| +0% | +$10.7K | 0.04% | 477 |
|
|
2025
Q4 | $33.4M | Buy |
110,204
+43,655
| +66% | +$13.6M | 0.04% | 430 |
|
|
2025
Q3 | $18.7M | Buy |
66,549
+12,310
| +23% | +$3.35M | 0.02% | 613 |
|
|
2025
Q2 | $13.1M | Buy |
54,239
+37,893
| +232% | +$8.96M | 0.02% | 718 |
|
|
2025
Q1 | $3.98M | Buy |
+16,346
| New | +$4.92M | 0.01% | 1217 |
|
|
2024
Q3 | – | Sell |
-2,951
| Closed | -$806K | – | 2190 |
|
|
2024
Q2 | $806K | Buy |
2,951
+57
| +2% | +$16.6K | ﹤0.01% | 1660 |
|
|
2024
Q1 | $1M | Sell |
2,894
-1,254
| -30% | -$412K | ﹤0.01% | 1413 |
|
|
2023
Q4 | $1.34M | Sell |
4,148
-1,355
| -25% | -$425K | ﹤0.01% | 1485 |
|
|
2023
Q3 | $1.97M | Sell |
5,503
-6,488
| -54% | -$2.5M | ﹤0.01% | 1443 |
|
|
2023
Q2 | $4.55M | Sell |
11,991
-13,201
| -52% | -$5.37M | 0.01% | 908 |
|
|
2023
Q1 | $12.1M | Sell |
25,192
-64,982
| -72% | -$30.4M | 0.03% | 622 |
|
|
2022
Q4 | $37.9M | Buy |
90,174
+22,035
| +32% | +$8.89M | 0.08% | 282 |
|
|
2022
Q3 | $28.4M | Sell |
68,139
-4,995
| -7% | -$2.49M | 0.07% | 344 |
|
|
2022
Q2 | $36.2M | Buy |
73,134
+8,040
| +12% | +$4.19M | 0.04% | 501 |
|
|
2022
Q1 | $36.7M | Buy |
65,094
+6,936
| +12% | +$4.18M | 0.03% | 549 |
|
|
2021
Q4 | $43.9M | Buy |
58,158
+20,905
| +56% | +$15.6M | 0.03% | 514 |
|
|
2021
Q3 | $27.8M | Buy |
37,253
+2,491
| +7% | +$1.87M | 0.02% | 609 |
|
|
2021
Q2 | $22.4M | Sell |
34,762
-1,937
| -5% | -$1.18M | 0.02% | 596 |
|
|
2021
Q1 | $21M | Buy |
36,699
+9,720
| +36% | +$5.76M | 0.02% | 605 |
|
|
2020
Q4 | $15.7M | Sell |
26,979
-143
| -0.5% | -$81.4K | 0.02% | 694 |
|
|
2020
Q3 | $14M | Sell |
27,122
-12,782
| -32% | -$6.47M | 0.02% | 680 |
|
|
2020
Q2 | $18M | Sell |
39,904
-25,816
| -39% | -$11.4M | 0.02% | 670 |
|
|
2020
Q1 | $23M | Sell |
65,720
-21,920
| -25% | -$8.06M | 0.03% | 510 |
|
|
2019
Q4 | $32.4M | Buy |
87,640
+5,475
| +7% | +$1.93M | 0.03% | 571 |
|
|
2019
Q3 | $27.3M | Buy |
82,165
+37,096
| +82% | +$12.1M | 0.03% | 650 |
|
|
2019
Q2 | $14.1M | Sell |
45,069
-3,386
| -7% | -$1.01M | 0.01% | 993 |
|
|
2019
Q1 | $14.8M | Sell |
48,455
-13,641
| -22% | -$3.68M | 0.02% | 900 |
|
|
2018
Q4 | $14.4M | Sell |
62,096
-2,272
| -4% | -$610K | 0.02% | 911 |
|
|
2018
Q3 | $20.1M | Buy |
64,368
+45
| +0.1% | +$14K | 0.02% | 891 |
|
|
2018
Q2 | $18.6M | Buy |
64,323
+125
| +0.2% | +$34.5K | 0.02% | 924 |
|
|
2018
Q1 | $16.1M | Sell |
64,198
-1,811
| -3% | -$461K | 0.02% | 1004 |
|
|
2017
Q4 | $15.8M | Sell |
66,009
-7,454
| -10% | -$1.81M | 0.02% | 1096 |
|
|
2017
Q3 | $16.3M | Buy |
73,463
+22,755
| +45% | +$5.12M | 0.02% | 1076 |
|
|
2017
Q2 | $11.5M | Buy |
50,708
+48,698
| +2,423% | +$10.6M | 0.01% | 1258 |
|
|
2017
Q1 | $401K | Buy |
2,010
+895
| +80% | +$172K | ﹤0.01% | 2445 |
|
|
2016
Q4 | $203K | Sell |
1,115
-4,156
| -79% | -$709K | ﹤0.01% | 2529 |
|
|
2016
Q3 | $863K | Buy |
5,271
+2,991
| +131% | +$454K | ﹤0.01% | 2248 |
|
|
2016
Q2 | $326K | Sell |
2,280
-165
| -7% | -$23.5K | ﹤0.01% | 2404 |
|
|
2016
Q1 | $334K | Sell |
2,445
-2,595
| -51% | -$341K | ﹤0.01% | 2332 |
|
|
2015
Q4 | $699K | Sell |
5,040
-300
| -6% | -$41.6K | ﹤0.01% | 2111 |
|
|
2015
Q3 | $717K | Sell |
5,340
-1,500
| -22% | -$216K | ﹤0.01% | 1949 |
|
|
2015
Q2 | $1.03M | Buy |
6,840
+5,235
| +326% | +$749K | ﹤0.01% | 1946 |
|
|
2015
Q1 | $217K | Buy |
+1,605
| New | +$199K | ﹤0.01% | 2185 |
|
Other funds holding BIO
VCM
VPM
AI
